Literature DB >> 7577469

Molecular and immunohistochemical analysis of P53 in phaeochromocytoma.

P L Dahia1, R C Aguiar, A M Tsanaclis, I Bendit, S P Bydlowski, N M Abelin, S P Toledo.   

Abstract

We searched for mutations of the p53 gene in 25 phaeochromocytomas using polymerase chain reaction-single strand conformation polymorphism (PCR-SSCP) analysis of the entire conserved region of the gene, encompassing exons 4-8; expression of the p53 protein was assessed by immunohistochemistry. No mutations were found, while a polymorphism in codon 72 was observed. Immunohistochemistry revealed nuclear p53 overexpression in one tumour sample. We conclude that mutations of the 'hotspot' region of the p53 gene do not seem to play a role in the pathogenesis of phaeochromocytoma.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7577469      PMCID: PMC2033918          DOI: 10.1038/bjc.1995.487

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  15 in total

1.  The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation.

Authors:  J Momand; G P Zambetti; D C Olson; D George; A J Levine
Journal:  Cell       Date:  1992-06-26       Impact factor: 41.582

2.  Expression of mutant p53 proteins in lung cancer correlates with the class of p53 gene mutation.

Authors:  S M Bodner; J D Minna; S M Jensen; D D'Amico; D Carbone; T Mitsudomi; J Fedorko; D L Buchhagen; M M Nau; A F Gazdar
Journal:  Oncogene       Date:  1992-04       Impact factor: 9.867

3.  The cycling pool of cells within human brain tumors: in situ cytokinetics using the monoclonal antibody Ki-67.

Authors:  A M Tsanaclis; F Robert; J Michaud; S Brem
Journal:  Can J Neurol Sci       Date:  1991-02       Impact factor: 2.104

4.  Polymorphism at codon 72 of the p53 gene in human acute myelogenous leukemia.

Authors:  W Zhang; G Hu; A Deisseroth
Journal:  Gene       Date:  1992-08-15       Impact factor: 3.688

5.  Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus.

Authors:  D Viskochil; A M Buchberg; G Xu; R M Cawthon; J Stevens; R K Wolff; M Culver; J C Carey; N G Copeland; N A Jenkins
Journal:  Cell       Date:  1990-07-13       Impact factor: 41.582

6.  Loss of heterozygosity suggests multiple genetic alterations in pheochromocytomas and medullary thyroid carcinomas.

Authors:  S Khosla; V M Patel; I D Hay; D J Schaid; C S Grant; J A van Heerden; S N Thibodeau
Journal:  J Clin Invest       Date:  1991-05       Impact factor: 14.808

Review 7.  p53 mutations in human cancers.

Authors:  M Hollstein; D Sidransky; B Vogelstein; C C Harris
Journal:  Science       Date:  1991-07-05       Impact factor: 47.728

8.  Role of p53 mutations in endocrine tumorigenesis: mutation detection by polymerase chain reaction-single strand conformation polymorphism.

Authors:  K Yoshimoto; H Iwahana; A Fukuda; T Sano; S Saito; M Itakura
Journal:  Cancer Res       Date:  1992-09-15       Impact factor: 12.701

9.  Allelic frequency of a p53 polymorphism in human lung cancer.

Authors:  A Weston; L S Perrin; K Forrester; R N Hoover; B F Trump; C C Harris; N E Caporaso
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  1992 Sep-Oct       Impact factor: 4.254

10.  Inactivation of the p53 gene is not required for tumorigenesis of medullary thyroid carcinoma or pheochromocytoma.

Authors:  I Yana; T Nakamura; E Shin; K Karakawa; H Kurahashi; Y Kurita; T Kobayashi; T Mori; I Nishisho; S Takai
Journal:  Jpn J Cancer Res       Date:  1992-11
View more
  6 in total

1.  Malignant paraganglioma of the urinary bladder: Immunohistochemical study of prognostic indicators.

Authors:  Kalman Kovacs; David Bell; Geoffrey W Gardiner; R John Honey; Jeannette Goguen; Fabio Rotondo
Journal:  Endocr Pathol       Date:  2005       Impact factor: 3.943

2.  The clinicopathological features and importance of p53, Rb, and mdm2 expression in phaeochromocytomas and paragangliomas.

Authors:  K Y Lam; C Y Lo; N M Wat; J M Luk; K S Lam
Journal:  J Clin Pathol       Date:  2001-06       Impact factor: 3.411

3.  Bcl-2 and c-Myc, but not bax and p53, are expressed during human medullary thyroid tumorigenesis.

Authors:  D G Wang; W H Liu; C F Johnston; J M Sloan; K D Buchanan
Journal:  Am J Pathol       Date:  1998-06       Impact factor: 4.307

4.  p53 protein and its messenger ribonucleic acid in human adrenal tumors.

Authors:  V Adleff; K Rácz; M Tóth; I Varga; A Bezzegh; E Gláz
Journal:  J Endocrinol Invest       Date:  1998-12       Impact factor: 4.256

Review 5.  Molecular genetic alterations in adrenal and extra-adrenal pheochromocytomas and paragangliomas.

Authors:  Hilde Dannenberg; Paul Komminoth; Winand N M Dinjens; Ernst Jan M Speel; Ronald R de Krijger
Journal:  Endocr Pathol       Date:  2003       Impact factor: 3.943

6.  Concurrent Pheochromocytoma, Paraganglioma, Papillary Thyroid Carcinoma, and Desmoid Tumor: A Case Report with Analyses at the Molecular Level.

Authors:  Lucio Scopsi; Luca Cozzaglio; Paola Collini; Maria Gullo; Italia Bongarzone; Monica Giarola; Paolo Radice; Leandro Gennari
Journal:  Endocr Pathol       Date:  1998       Impact factor: 3.943

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.